Allosteric cross-talk in chromatin can mediate drug-drug synergy
Allostery and drug-drug synergism can yield potential novel therapies with existing molecules. Here, the authors provide evidence that two unrelated drugs have increased cytotoxicity in cancer cells, which coincides with increased formation of chromatin adducts.
Guardado en:
Autores principales: | Zenita Adhireksan, Giulia Palermo, Tina Riedel, Zhujun Ma, Reyhan Muhammad, Ursula Rothlisberger, Paul J. Dyson, Curt A. Davey |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d1b4c81d2d84ca2b30e46381f058d95 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nucleosome acidic patch-targeting binuclear ruthenium compounds induce aberrant chromatin condensation
por: Gabriela E. Davey, et al.
Publicado: (2017) -
Near-atomic resolution structures of interdigitated nucleosome fibres
por: Zenita Adhireksan, et al.
Publicado: (2020) -
Optimal drug synergy in antimicrobial treatments.
por: Joseph Peter Torella, et al.
Publicado: (2010) -
The antidepressant drug vilazodone is an allosteric inhibitor of the serotonin transporter
por: Per Plenge, et al.
Publicado: (2021) -
Drug Repositioning For Allosteric Modulation of VIP and PACAP Receptors
por: Ingrid Langer, et al.
Publicado: (2021)